Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

INFLAMMATORY BOWEL DISEASE: Edited by Miguel Regueiro

Safety considerations with biologics and new inflammatory bowel disease therapies

Queiroz, Natália S.F.a; Regueiro, Miguelb

Author Information
Current Opinion in Gastroenterology: July 2020 - Volume 36 - Issue 4 - p 257-264
doi: 10.1097/MOG.0000000000000607
  • Buy

Abstract

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.